Talking Medicines secures £1.1 million funding deal
by Startacus Admin
.JPG)
Talking Medicines, the social intelligence company for the pharmaceutical industry, raises £1.1 million funding deal to scale up its AI-based data technology platform for measuring patient sentiment
Good news for Talking Medicines, the world’s first social intelligence company for the pharmaceutical industry, with the announcement that it has received a major boost with a £1.1 million funding deal to scale up its AI-based data technology platform for measuring patient sentiment.
Tern Plc, the investment company specialising in the Internet of Things (“IoT”), is the lead investor in a syndicated funding round of £1,100,000 alongside The Scottish Investment Bank, Scottish Enterprise’s investment arm.
Led by CEO Jo Halliday alongside co-founders Dr Elizabeth Fairley and Dr Scott Crae, Talking Medicines will use the funds to support the launch and roll-out of a new AI data platform, which will translate what patients are saying into actionable pharma grade intelligence by providing a global patient confidence score by medicine. As part of these plans, the business intends to immediately recruit 9 new employees to the NLP data tech team.
Glasgow-based Talking Medicines uses a combination of Artificial Intelligence, Machine Learning and Natural Language Processing tech tools to capture and analyse the conversations and behaviours of patients at home, with the aim of transforming big pharma’s understanding of patient sentiment.
Through mapping the patient voice from social media and connected devices to regulated medicine information, Talking Medicines is able to build data points to determine trends and patterns of patient sentiment across medicines. This intelligence enables pharmaceutical companies to make patient centric marketing decisions, driving more effective medicines and marketing spend.
Real-time, compliant intelligence can replace traditional focus groups, prescriber reports and clinical target patient profiles to tell pharmaceutical companies who is using their medicines, how, and what they really think of their brands.
Talking Medicines has now raised £2.5 million to date and since launching 7 years ago, the business has scooped a number of accolades for its innovative approach including winning Rising Stars 2.0, a competition to select the rising stars of UK tech.
Talking Medicines CEO, Jo Halliday, said: “We are delighted that Tern is joining our investor group, and Al Sisto will be bringing his wealth of experience to the Board. Now more than ever we passionately believe that big pharma needs a systematic way to make data driven decisions through accessing high grade social intelligence driven from the patient.”
Subscribe to our newsletter
If you would like to receive our startup themed newsletter, full of the latest startup opportunities, events, news, stories, tips and advice, then sign up here.
 (1).png)
The UK’s fastest-growing plant-based meat brand, THIS™ set to launch Seedrs campaign to support further innovation, bold marketing and international expansion.
CropSafe, a platform revolutionizing the future of farming, announce that they have raised over $3M in seed funding and have opened U.S. headquarters in Los Angeles.
Voicy, the online content platform for discovering, creating and sharing sound-clips and sound-effects secures investment to support team expansion and global growth.
.jpg)
Career Masterclass has launched a new website to showcase its offerings, as a strategic partner for businesses wanting to bolster D&I policies.
NI Startup? Fancy showcasing your startup at this year's Digital DNA event? We've got up to 10 spaces for NI startups to do just that. Here's the details!
Germany's leading digital solar platform, Zolar secures major investment to support roll out of new digital energy products.
Metro Bank seeks startups and scaleups with a focus on customer experience, community banking, optimisation of systems & data and sustainability for its second innovation lab.
Need a little extra motivation to get your daily step count up? Treekly will help you do your bit for the climate crisis with every step you take...
The lowdown on London-based SaaS startup Adadot and its innovative performance and wellbeing tracking platform for developers.
.jpg)
Henrik Grim, European GM of Capchase shares insights on how founders can navigate these more challenging funding conditions.
Published on: 4th November 2020
If you would like to enable commenting via your Startacus account, please enable Disqus functionality in your Account Settings.
- Voicy lands €1.2 million pre-Seed from Global Founders Capital to build the GIPHY for sound 20th May 2022 Voicy, the online content platform for discovering, creating and sharing sound-clips and sound-effects secures investment to support team expansion and global growth.
- Zolar Lands €100 Million Series C On The Back Of Surging Demand For Affordable Green Energy 19th May 2022 Germany's leading digital solar platform, Zolar secures major investment to support roll out of new digital energy products.
- Metro Bank opens call for participants for second Magic Makers programme 17th May 2022 Metro Bank seeks startups and scaleups with a focus on customer experience, community banking, optimisation of systems & data and sustainability for its second innovation lab.
- Storyblok Raises $47M Series B to Make Headless Content Management the New Standard 17th May 2022 Storyblok secures major investment to further accelerate product innovation and growth into the US and Europe.
